Efficacy of Electrical Pudendal Nerve Stimulation and Sacral in Treating Non-obstructive Neurogenic Urinary Retention

Inclusion Criteria: * Non-mechanical obstructive urinary retention occurs following relevant neurological system disorders (spinal cord injury, spina bifida，myelitis, cervical/thoracic disk disease, lesion following spinal anesthesia/spine surgery,lumbar/sacral spine intervertebral disc diseases, spinal stenosis, iatrogenic pelvic nerve lesions, sacral agenesis, peripheral neuropathy due to diabetes mellitus). * With normal upper urinary tract function. * Other therapies and medications potentially affecting the assessment of this therapy have been discontinued for at least two weeks before the interventional procedure. * Patient with good compliance who is capable of cooperating with the follow-up requirements Exclusion Criteria: * Patients with any suprapontine and pontine lesions * Pregnant or lactating women * Individuals whose symptoms show significant improvement after pharmaceutical and adjunctive therapy * Individuals with concurrent acute or chronic prostatitis, prostate cancer, or conditions such as bladder neck stenosis, urethral stricture, or urethral injury * High pathological risk factors (e.g., lymph node metastasis, resection margin involvement, bulky tumors) * Individuals with concomitant obstructive urinary retention